NakedMD Scales Injectable Concept With Corporate Operations and Narrow Menu
Beauty Independent reports that medical aesthetics chain NakedMD has grown its studio count by over 2,400 percent since its 2022 founding. By focusing on a limited service menu and rejecting franchising in favor of corporate ownership, the California-based company aims to standardize injectable treatments across its rapidly expanding national footprint.
Context from Industry Pulse
NakedMD is expanding during a period of consolidation within the medical aesthetics sector. While over 90 percent of medical spas are currently independent, private equity interest is rising as investors seek to build dominant, recognizable brands. Data from Guidepoint Qsight indicates that U.S. spending on nonsurgical aesthetics reached 21 billion dollars in 2025, with neurotoxins and fillers representing nearly half of that total market. NakedMD competes alongside other backed chains like SkinSpirit and LaserAway. Its backer, Revelstoke Capital Partners, has further diversified its position in the segment by also investing in Evolve Medspa, signaling a strategic bet on the long-term scalability of injectable-focused business models.
"Ironically, we’re innovative on the process side, the training side and the reproducibility, but we try to actually go with very old-school products."
Founded in Newport Beach, NakedMD has scaled from just two locations in 2022 to more than 50 studios today. As Beauty Independent reports, this rapid expansion followed an investment from private equity firm Revelstoke Capital Partners in 2024. The company has already moved into markets like New York and Boston, with plans to enter North Carolina and South Carolina in the near future. Unlike many of its competitors in the medical spa sector, the brand maintains total control over its operations by eschewing the franchise model.
The business strategy focuses on a highly specialized menu rather than offering the broad array of services found at traditional medical spas. According to Beauty Independent, the offerings are limited to neurotoxins, dermal fillers, and biostimulators. This streamlined approach allows the company to emphasize affordability, with advertised prices for neurotoxin treatments starting below seventy dollars. To encourage repeat business, the chain offers a monthly membership program that provides discounted per-unit pricing on popular injections and markdowns on retail skincare products.
Maintaining clinical consistency is a primary objective for the leadership team as the workforce grows. Beauty Independent notes that the company operates an internal training academy to manage more than 270 registered nurses and nurse practitioners. This infrastructure supports weekly clinical reviews and a digital system for sharing injection techniques in real time. The brand focuses on using established products rather than chasing new trends, prioritizing reproducible results across its entire network of providers.
Expansion decisions are driven by digital marketing data and local demographics. Beauty Independent explains that the company tests consumer interest in a market before committing to a physical site. While this data-centric model has fueled growth, the company has faced internal operational hurdles related to communication and logistics as it opens multiple new storefronts simultaneously. Despite these challenges, the chain continues to target a fragmented market where the vast majority of medical spas remain independent.
The Industry Pulse Bottom Line
NakedMD’s rapid growth demonstrates how a simplified, corporate-owned model can gain traction in a fragmented market. By prioritizing standardized training and data-driven site selection over service variety, the chain aims to become a predictable national leader in injectables.